Moderna (MRNA) Share-based Compensation Growth (3y) (2021 - 2026)
Moderna (MRNA) Share-based Compensation Growth (3y) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Stock Comp. Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
4.80% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
10.78% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Moderna |
25.27 Bn |
20.06 Bn |
-566.00 Mn |
11.51% |
| Date | Value |
|---|
| Mar 31, 2026 |
11.51% |
| Dec 31, 2025 |
22.15% |
| Sep 30, 2025 |
21.32% |
| Jun 30, 2025 |
37.51% |
| Mar 31, 2025 |
37.75% |
| Dec 31, 2024 |
41.13% |
| Sep 30, 2024 |
40.95% |
| Jun 30, 2024 |
47.36% |
| Mar 31, 2024 |
49.88% |
| Dec 31, 2023 |
44.84% |
| Sep 30, 2023 |
51.83% |
| Jun 30, 2023 |
43.58% |
| Mar 31, 2023 |
55.36% |
| Dec 31, 2022 |
45.32% |
| Sep 30, 2022 |
49.85% |
| Jun 30, 2022 |
32.50% |
| Mar 31, 2022 |
33.49% |
| Dec 31, 2021 |
5.35% |
| Sep 30, 2021 |
39.55% |
| Jun 30, 2021 |
34.60% |
